JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Identification of N6-methyladenosine-associated ferroptosis biomarkers in cervical cancer

  • 0Department of Chinese Pharmacy, School of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China.
Hereditas +

|

April 8, 2025

|

April 8, 2025

View abstract on PubMed

Summary

This summary is machine-generated.

This study identifies six key genes (ALOX12, EZH2, CA9, CDCA3, CDC25A, HSPB1) as crucial m6A-regulated ferroptosis biomarkers for cervical cancer (CC). These biomarkers offer new insights into CC pathogenesis and potential therapeutic targets.

Area Of Science

  • Oncology
  • Molecular Biology
  • Bioinformatics

Background

  • Cervical cancer (CC) is a significant cause of mortality in women, with complex pathogenesis.
  • Understanding the roles of ferroptosis and N6-methyladenosine (m6A) RNA methylation is crucial for CC research.

Purpose Of The Study

  • To investigate the mechanisms of ferroptosis and m6A RNA methylation in cervical cancer using bioinformatics.
  • To identify novel biomarkers for CC diagnosis and prognosis.

Main Methods

  • Utilized three CC datasets (GSE9750, GSE63514, TCGA-CESC) and curated gene databases for m6A and ferroptosis.
  • Performed differential expression, correlation, and machine learning analyses to identify key genes.
  • Conducted Gene Set Enrichment Analysis (GSEA), Kaplan-Meier (KM) survival analysis, and constructed a competing endogenous RNA (ceRNA) network.
  • Verified biomarker expression using real-time quantitative polymerase chain reaction (RT-qPCR).

Main Results

  • Identified six differentially expressed m6A-related ferroptosis genes (DE-MRFGs): ALOX12, EZH2, CA9, CDCA3, CDC25A, and HSPB1.
  • A nomogram based on these biomarkers showed promising diagnostic value for CC.
  • GSEA linked biomarkers to cell proliferation and DNA repair pathways; KM analysis highlighted HSPB1, EZH2, and CA9 as prognostic indicators.
  • RT-qPCR confirmed elevated expression of ALOX12, EZH2, and CDC25A in CC tissues, while HSPB1 was higher in controls.

Conclusions

  • Six genes (ALOX12, EZH2, CA9, CDCA3, CDC25A, HSPB1) are identified as m6A-regulated ferroptosis biomarkers in cervical cancer.
  • These findings provide valuable insights into CC pathogenesis.
  • The identified biomarkers hold potential for improving CC diagnosis, treatment, and prognosis.

Keywords: